2020 American Transplant Congress
Living Liver Donation in Previous Kidney Donors – A Valuable Resource for Hepatic Allografts without Compromising Donor Safety
Cleveland Clinic, Cleveland, OH
*Purpose: Living liver donation in Western nations permits a valuable expansion of the donor pool beyond the majority of deceased donors, whilst conversely providing the…2020 American Transplant Congress
The Experience of 1000 Cases of Hand Assisted Laparoscopic Donor Nephrectomy for Living Donor Kidney Transplantation
*Purpose: Due to the increasing number of kidney transplant candidates, living donor kidney transplantation becomes more necessary. For living donor kidney transplantation, safe and efficient…2020 American Transplant Congress
Optical Trocar Entry Technique in Laparoscopic Donor Nephrectomy
*Purpose: The published data of safety, practicality and applicability of the optical trocar entry technique in laparoscopic donor nephrectomy in general have been previously investigated.…2020 American Transplant Congress
Self-Reported Marijuana Use and its Effects on Overall Approval in Potential Living Kidney Donors
Kidney & Pancreas Transplant, Cleveland Clinic, Cleveland, OH
*Purpose: Past and present substance use is an important part of the psychosocial evaluation of potential living kidney donors. Increasing state legalizations and social acceptance…2020 American Transplant Congress
Long-Term Outcomes for Living Kidney Donors: A Japanese Single-Center Experience
Urology, Hokkaido University Hospital, Sapporo, Japan
*Purpose: Previous studies suggested that live kidney donors do not have a higher risk of death or end-stage kidney disease (ESKD) than the general population.…2020 American Transplant Congress
Additive Effect of Obesity to Hypertension in Living Donors and Their Impact on Glomerular Filtration Rate Compensation with 5 Year Follow-Up
*Purpose: Current data suggest that hypertensive donors can be considered for donation; however, the additive adverse effect of obesity and the risk of failing Glomerular…2020 American Transplant Congress
Interim Experience in a Phase 3 Prospective, Randomized, Multi-Center, Open-Label, Controlled Trial of Cellular Immunotherapy with MDR-101 for Induction of Immune Tolerance in Recipients of HLA-Matched, Living Donor Kidney Transplants
*Purpose: The goals of tolerance in patients with kidney transplants (KTxp) are to eliminate the lifelong need for immunosuppressive drugs (IS) and to prevent graft…2020 American Transplant Congress
Paired Exchange Living Donor Liver Transplantation Using Compatible Pairs- U.S. Single Center Experience
University of Texas Health San Antonio, San Antonio, TX
*Purpose: ABO and size incompatibility are common reasons for non-acceptance of otherwise suitable donors in Living Donor Liver Transplantation (LDLT). Paired exchange LDLT has been…2020 American Transplant Congress
Retroperitoneoscpic Donor Nephrectomy in the Right Side Provides Excellent Outcomes and Donor Safety Comparable with Left Side
Renal and Genitourinary Surgery, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
*Purpose: The left kidney is usually selected for laparoscopic donor nephrectomy while the right kidney raises concerns for donors’ and recipients’ safety and presents a…2020 American Transplant Congress
Serum αKlotho after Living Kidney Donation: A Systematic Review and Meta-Analysis
*Purpose: αKlotho (klotho) is a known anti-aging protein that exerts diverse physiological effects. Defect in klotho gene expression in mice can result in a syndrome…
- « Previous Page
- 1
- …
- 19
- 20
- 21
- 22
- 23
- …
- 27
- Next Page »